Company Filing History:

4 out of 37

Hyseq, Inc.

patents

4 out of 336

Cambridge Enterprise Limited

Bgi-shenzhen Co., Limited

Washington University

patents

Years Active: 2002-2019

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10407738 - Markers for breast cancer (2019-09-10),

2. 9890375 - Isolated oligonucleotide and use thereof in nucleic acid sequencing (2018-02-13),

3. 9702011 - Markers for breast cancer (2017-07-11),

4. 9068229 - Markers for breast cancer (2015-06-30),

5. 9051617 - Markers for breast cancer (2015-06-09),

6. 8080371 - Markers for addiction (2011-12-20),

7. 6706871 - Growth factor antagonist materials and methods (2004-03-16),

8. 6485920 - Growth factor antagonist materials and methods (2002-11-26),

9. 6423682 - Sprouty related growth factor antagonist (FGFAn-Hy) materials and methods (2002-07-23),

10. 6372892 - Interleukin—1 Hy2 materials and methods (2002-04-16),

11. 6365726 - Polynucleotides encoding IL-1 Hy2 polypeptides (2002-04-02),

12. 6339141 - Interleukin-1 Hy2 materials and methods (2002-01-15),

Title: Innovations and Contributions of Dennis G Ballinger

Introduction

Dennis G Ballinger is a notable inventor based in Menlo, California, with a remarkable portfolio of 12 patents. His work primarily focuses on advancements in the field of breast cancer diagnosis and treatment, showcasing his commitment to improving healthcare outcomes.

Latest Patents

Among his latest patents, Ballinger has developed innovative markers for breast cancer, providing correlations between polymorphisms and the disease. He has also created methods for diagnosing, prognosing, and treating breast cancer, along with systems and kits designed for these purposes. Additionally, he has described methods for identifying breast cancer modulators. Another significant patent involves an isolated oligonucleotide used in nucleic acid sequencing, which features a unique double-stranded structure that enhances the sequencing process.

Career Highlights

Throughout his career, Dennis G Ballinger has made significant contributions to the field of biotechnology. He has worked with reputable companies such as Hyseq, Inc. and Cambridge Enterprise Limited, where he has applied his expertise to develop groundbreaking technologies.

Collaborations

Ballinger has collaborated with esteemed colleagues, including David R Cox and Bruce Ponder, further enriching his research and innovation efforts.

Conclusion

Dennis G Ballinger's contributions to breast cancer research and biotechnology exemplify his dedication to innovation and improving patient care. His extensive patent portfolio reflects his significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.